Physician profile
William Syska
NPI 1104051424
$1,384.46
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $888 · 2022: $201 · 2023: $261 · 2024: $33.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $311.38 | 2021-2023 | Evenity |
| Boston Scientific Corporation | $127.81 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Radius Health, INC. | $112.73 | 2021 | |
| Scilex Pharmaceuticals INC. | $111.08 | 2021-2023 | Ztlido |
| Tersera Therapeutics LLC | $78.62 | 2021 | |
| Medtronic, INC. | $62.51 | 2021 | |
| Biodelivery Sciences International, INC. | $57.87 | 2021 | |
| Almatica Pharma LLC | $55.48 | 2021 | |
| Arbor Pharmaceuticals, INC. | $53.47 | 2021 | |
| Allergan, INC. | $44.65 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $40.66 | 2022-2023 | Dysport |
| Si-Bone, INC. | $38.95 | 2021 | |
| Depuy Synthes Sales INC. | $31.65 | 2021 | |
| Vertos Medical, INC. | $31.04 | 2022 | |
| Grt US Holding, INC. | $30.66 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $28.86 | 2021 | |
| Abbott Laboratories | $27.66 | 2022 | |
| Nevro Corp. | $26.65 | 2022 | |
| Pacira Therapeutics, INC. | $23.90 | 2021 | |
| Spr Therapeutics, INC | $18.57 | 2021 | |
| Protega Pharmaceutials INC | $16.24 | 2023 | Roxybond |
| Abbvie INC. | $15.37 | 2023 | |
| Fidia Pharma USA INC. | $14.93 | 2023 | Hymovis |
| Forte Bio-Pharma LLC | $12.24 | 2021 | |
| Electronic Waveform Lab, INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Syska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.